• Publications
  • Influence
QbD approach to investigate product and process variabilities for brain targeting liposomes
Abstract Efficacy of central nervous system-acting medications is limited by its localization and ability to cross the blood–brain barrier (BBB); therefore, the crux is in designing delivery systemsExpand
  • 8